Etude de marché - Biotechnologies et Génétique

Mon compte | Mon panier (0) | Contactez-nous | Abonnez-vous !

Résultats 251 - 260 de 479 sur 26 éditeurs


Biotechnologies et Génétique

RSS_US

RSS_FR

GTC Biotherapeutics, Inc. - SWOT Analysis
Datamonitor \| 26 pages \| Mai 2007 \| Anglais
Datamonitor's GTC Biotherapeutics, Inc. - SWOT Analysis Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structu ...	100,00 €

Monoclonal Antibody Therapy
TriMark \| 8 pages \| Janvier 2007 \| Anglais
The ``Sector Snapshot`` is designed to provide a high-level overview of a particular market sector, including key players, sales data and emerging trends. This sector snapshot discusses about the m ...	400,00 €

U.S. Biotech Industry Statistics, 1994-2003
TriMark \| 1 page \| Mars 2006 \| Anglais
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...	80,00 €

Global Market for Bioactive Materials, 2004-2006
TriMark \| 1 page \| Janvier 2007 \| Anglais
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...	80,00 €

Global Biotechnology industry update Jan-Jun 2006
Cygnus Business Consulting & Research \| 32 pages \| Juin 2006 \| Anglais
The global biotechnology industry is estimated to be about USD34.9 billion by the end of June 2006, posting a 11% increase when compared with the biotech industry as a whole, which was at an estimated ...	200,00 €

Revolutionise Drug Discovery through Genomics & Proteomics Study
Rocsearch \| 10 pages \| Novembre 2002 \| Anglais
Genomics and Proteomics are complementary technologies of biological research. The potential of these technologies for biomedical revolution will be realized by integrating them into the drug disc ...	200,00 €

Pipeline Insight: Hepatitis C - Small Molecules, Big Revolution
Datamonitor \| 237 pages \| Avril 2005 \| Anglais
IntroductionLess than 50% of chronically infected hepatitis C patients do not benefit from the current standard of care, pegylated interferon plus ribavirin. In the short-term, the treatment landsc ...	9.120,00 €

Amount of Financing of Biotech Companies, 1998-2004
TriMark \| 1 page \| Mars 2006 \| Anglais
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specif ...	80,00 €

Biogenerics, The World Market: Biosimilars and Biologics at a Crossroads
Kalorama Information \| 1 page \| Janvier 2008 \| Anglais
The biopharmaceutical market is at a crossroads. Some of the biggest-selling biologics developed during the first phase of the biotechnology revolution in the 1980s, including human growth hormone ...	2.800,00 €

03-052A: Protein Purification Systems: Market Opportunities for Research Product Suppliers
BioInformatics \| 163 pages \| Octobre 2003 \| Anglais
This report will help suppliers exploit opportunities to differentiate themselves from their competitors and develop more advanced protein purification tools ...	960,00 €

1	\|	2	\|	3	\|	4	\|	5	\|	6	\|	7	\|	8	\|	9	\|	10	\|	11	\|	12	\|	13	\|	14	\|	15	\|	16	\|	17	\|	18	\|	19	\|	20	\|	21	\|	22	\|	23	\|	24	\|	25	\|
26	\|
27	\|	28	\|	29	\|	30	\|	31	\|	32	\|	33	\|	34	\|	35	\|	36	\|	37	\|	38	\|	39	\|	40	\|	41	\|	42	\|	43	\|	44	\|	45	\|	46	\|	47	\|	48	\|

CIPLS